Preoperative lanreotide treatment improves outcome in patients with acromegaly resulting from invasive pituitary macroadenoma.
about
MicroRNA-145 inhibits the activation of the mTOR signaling pathway to suppress the proliferation and invasion of invasive pituitary adenoma cells by targeting AKT3 in vivo and in vitro.The place of medical treatment of acromegaly: current status and perspectives.Pharmacological treatment of acromegaly: its place in the overall therapeutic approach.Should all patients with acromegaly receive somatostatin analogue therapy before surgery and, if so, for how long?Preoperative somatostatin analogues versus direct transsphenoidal surgery for newly-diagnosed acromegaly patients: a systematic review and meta-analysis using the GRADE system.Surgery induced hypopituitarism in acromegalic patients: a systematic review and meta-analysis of the results.Prolonged preoperative treatment of acromegaly with Somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1-3): a retrospective cohort study conducted at a single center.Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complications.Preoperative octreotide therapy and surgery in acromegaly: associations between glucose homeostasis and treatment response.How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review.Updates in Diagnosis and Treatment of Acromegaly
P2860
Q37714078-7B25D4BB-49A7-47E5-83F6-86DD1466EFF4Q38100275-F5940C60-2313-46E8-820B-9DCC6FA9F2A3Q38179982-2C3EF934-2D1F-481E-9FEC-5254061AEB9EQ38231413-3A881644-4B48-4F45-B740-9DB000055840Q38254872-373C899B-5CD0-4031-B79D-D390C68D51FCQ38538268-D5D7FEB2-706D-4863-9BC2-2FAB68FFE93FQ41624853-D3982061-A879-43DA-8B2B-07C0FE8EDD79Q45067448-05CA105A-FC7D-4231-AEAF-893BE9EC84D4Q51299912-353BC731-4251-4990-8F11-5889793D9A8EQ54939988-FE96C5AA-3E29-43B0-85DC-927AACC859A6Q57822729-669B24DA-9E99-4F49-81AB-A9FBE3CA87D2
P2860
Preoperative lanreotide treatment improves outcome in patients with acromegaly resulting from invasive pituitary macroadenoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Preoperative lanreotide treatm ...... vasive pituitary macroadenoma.
@en
Preoperative lanreotide treatm ...... vasive pituitary macroadenoma.
@nl
type
label
Preoperative lanreotide treatm ...... vasive pituitary macroadenoma.
@en
Preoperative lanreotide treatm ...... vasive pituitary macroadenoma.
@nl
prefLabel
Preoperative lanreotide treatm ...... vasive pituitary macroadenoma.
@en
Preoperative lanreotide treatm ...... vasive pituitary macroadenoma.
@nl
P2093
P2860
P1476
Preoperative lanreotide treatm ...... vasive pituitary macroadenoma.
@en
P2093
P2860
P304
P356
10.1177/147323001204000213
P577
2012-01-01T00:00:00Z